Operaciones PharmaCyte Biotech, Inc. - PMCB CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.06 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Estadísticas clave
| Cierre previo* | 3.09 |
| Abrir* | 3.09 |
| Cambio de 1 año* | 44.39% |
| Rango del día* | 3.07 - 3.11 |
| Rango de 52 semanas | 1.95-3.15 |
| Volumen medio (10 días) | 53.35K |
| Volumen medio (3 meses) | 1.41M |
| Capitalización de mercado | 54.95M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 17.44M |
| Ingresos | N/A |
| EPS | -0.27 |
| Dividendo (Rendimiento %) | N/A |
| Beta | -0.03 |
| Próxima fecha de resultados | N/A |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| May 26, 2023 | 3.11 | 0.02 | 0.65% | 3.09 | 3.12 | 3.07 |
| May 25, 2023 | 3.09 | -0.01 | -0.32% | 3.10 | 3.10 | 3.09 |
| May 24, 2023 | 3.10 | 0.02 | 0.65% | 3.08 | 3.11 | 3.08 |
| May 23, 2023 | 3.09 | 0.01 | 0.32% | 3.08 | 3.10 | 3.08 |
| May 22, 2023 | 3.07 | 0.01 | 0.33% | 3.06 | 3.08 | 3.06 |
| May 19, 2023 | 3.05 | 0.01 | 0.33% | 3.04 | 3.06 | 3.03 |
| May 18, 2023 | 3.05 | 0.01 | 0.33% | 3.04 | 3.06 | 3.03 |
| May 17, 2023 | 3.05 | 0.01 | 0.33% | 3.04 | 3.07 | 3.03 |
| May 16, 2023 | 3.06 | 0.00 | 0.00% | 3.06 | 3.09 | 3.03 |
| May 15, 2023 | 3.05 | 0.02 | 0.66% | 3.03 | 3.08 | 3.03 |
| May 12, 2023 | 3.03 | -0.01 | -0.33% | 3.04 | 3.06 | 2.99 |
| May 11, 2023 | 3.05 | -0.02 | -0.65% | 3.07 | 3.07 | 2.98 |
| May 10, 2023 | 2.69 | -0.05 | -1.82% | 2.74 | 2.74 | 2.65 |
| May 9, 2023 | 2.74 | -0.01 | -0.36% | 2.75 | 2.75 | 2.73 |
| May 8, 2023 | 2.76 | -0.01 | -0.36% | 2.77 | 2.81 | 2.72 |
| May 5, 2023 | 2.78 | 0.04 | 1.46% | 2.74 | 2.78 | 2.74 |
| May 4, 2023 | 2.75 | -0.08 | -2.83% | 2.83 | 2.83 | 2.72 |
| May 3, 2023 | 2.83 | 0.00 | 0.00% | 2.83 | 2.85 | 2.83 |
| May 2, 2023 | 2.88 | 0.04 | 1.41% | 2.84 | 2.90 | 2.81 |
| May 1, 2023 | 2.89 | 0.03 | 1.05% | 2.86 | 2.90 | 2.83 |
PharmaCyte Biotech, Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 0 | 0 | 0 | 0 | 0 |
| Ingresos | 0 | 0 | 0 | 0 | 0 |
| Coste de los ingresos, total | |||||
| Beneficio bruto | |||||
| Gastos totales de explotación | 4.39201 | 3.547 | 3.8264 | 4.10063 | 6.98143 |
| Gastos de venta/general/administración Gastos, total | 3.70108 | 2.70673 | 3.52517 | 3.64058 | 4.98362 |
| Investigación y desarrollo | 0.69094 | 0.91625 | 0.30122 | 0.46005 | 1.99781 |
| Gastos (ingresos) extraordinarios | 0 | -0.07598 | |||
| Ingresos de explotación | -4.39201 | -3.547 | -3.8264 | -4.10063 | -6.98143 |
| Ingresos por intereses (gastos), netos No operativos | 0.15714 | -0.00305 | -0.00045 | 0 | |
| Otros, netos | -0.00428 | -0.00119 | -0.00004 | 0.0334 | 0.15259 |
| Ingresos netos antes de impuestos | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Ingresos netos después de impuestos | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Beneficio neto antes de partidas extra. Elementos | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Ingresos netos | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Beneficio neto diluido | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Promedio ponderado de acciones diluidas | 15.5217 | 1.44829 | 0.90833 | 0.73707 | 0.64899 |
| BPA diluido sin partidas extraordinarias | -0.27311 | -2.45203 | -4.2131 | -5.5181 | -10.5223 |
| Dividends per Share - Common Stock Primary Issue | |||||
| BPA normalizado diluido | -0.27311 | -2.50449 | -4.2131 | -5.5181 | -10.5223 |
| Total de partidas extraordinarias | 0 |
| Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 0 | 0 | 0 | 0 | 0 |
| Ingresos | 0 | 0 | 0 | 0 | 0 |
| Gastos totales de explotación | 1.55298 | 2.31862 | 1.68061 | 1.5077 | 0.85612 |
| Gastos de venta/general/administración Gastos, total | 1.50759 | 2.14062 | 1.52134 | 1.25364 | 0.69808 |
| Investigación y desarrollo | 0.04539 | 0.178 | 0.15927 | 0.25407 | 0.15804 |
| Ingresos de explotación | -1.55298 | -2.31862 | -1.68061 | -1.5077 | -0.85612 |
| Ingresos por intereses (gastos), netos No operativos | 0.63589 | 0.43917 | 0.1395 | 0.08657 | 0.04546 |
| Otros, netos | 0.15296 | -0.00106 | -0.00391 | -0.00157 | -0.00063 |
| Ingresos netos antes de impuestos | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Ingresos netos después de impuestos | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Beneficio neto antes de partidas extra. Elementos | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Ingresos netos | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Beneficio neto diluido | -0.76414 | -1.88051 | -1.54501 | -1.42271 | -0.81129 |
| Promedio ponderado de acciones diluidas | 18.9954 | 20.5854 | 20.8293 | 21.4702 | 21.6672 |
| BPA diluido sin partidas extraordinarias | -0.04023 | -0.09135 | -0.07417 | -0.06626 | -0.03744 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.04023 | -0.09135 | -0.07417 | -0.06626 | -0.03744 |
| Gastos (ingresos) extraordinarios | 0 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 85.4948 | 2.27524 | 1.03765 | 0.6534 | 1.28387 |
| Efectivo e inversiones a corto plazo | 85.4007 | 2.20211 | 0.89486 | 0.51525 | 1.0598 |
| Cash | 85.4007 | 2.20211 | 0.89486 | 0.51525 | 1.0598 |
| Prepaid Expenses | 0.09417 | 0.07313 | 0.14279 | 0.13815 | 0.22407 |
| Total Assets | 90.6241 | 7.40423 | 6.16664 | 5.7824 | 6.41286 |
| Intangibles, Net | 3.54943 | 3.54943 | 3.54943 | 3.54943 | 3.54943 |
| Long Term Investments | 1.57219 | 1.57219 | 1.57219 | 1.57219 | 1.57219 |
| Other Long Term Assets, Total | 0.00769 | 0.00737 | 0.00737 | 0.00737 | 0.00737 |
| Total Current Liabilities | 0.70437 | 0.72478 | 1.0314 | 0.74285 | 0.64417 |
| Accounts Payable | 0.20536 | 0.17226 | 0.18584 | 0.12189 | 0.35262 |
| Accrued Expenses | 0.49901 | 0.55252 | 0.81664 | 0.62097 | 0.29155 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | |||||
| Total Liabilities | 0.70437 | 0.72478 | 1.07768 | 0.74285 | 0.64417 |
| Total Long Term Debt | 0 | 0 | 0.04628 | 0 | 0 |
| Total Equity | 89.9198 | 6.67945 | 5.08896 | 5.03955 | 5.76869 |
| Common Stock | 0.00207 | 0.00016 | 0.16386 | 0.1186 | 0.10133 |
| Additional Paid-In Capital | 201.582 | 114.109 | 108.805 | 104.966 | 101.636 |
| Retained Earnings (Accumulated Deficit) | -111.649 | -107.41 | -103.858 | -100.031 | -95.9641 |
| Other Equity, Total | -0.01576 | -0.02038 | -0.02171 | -0.01384 | -0.00471 |
| Total Liabilities & Shareholders’ Equity | 90.6241 | 7.40423 | 6.16664 | 5.7824 | 6.41286 |
| Total Common Shares Outstanding | 20.7211 | 1.59008 | 1.09789 | 0.79462 | 0.67888 |
| Current Port. of LT Debt/Capital Leases | 0 | 0.02892 | |||
| Long Term Debt | 0 | 0.04628 |
| Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 72.8212 | 77.2194 | 82.2558 | 85.4948 | 86.8139 |
| Efectivo e inversiones a corto plazo | 72.6402 | 76.9626 | 82.2276 | 85.4007 | 86.6398 |
| Cash | 72.6402 | 76.9626 | 82.2276 | 85.4007 | 86.6398 |
| Prepaid Expenses | 0.18101 | 0.25681 | 0.02815 | 0.09417 | 0.1741 |
| Total Assets | 77.9505 | 82.3487 | 87.3851 | 90.6241 | 91.9432 |
| Intangibles, Net | 3.54943 | 3.54943 | 3.54943 | 3.54943 | 3.54943 |
| Long Term Investments | 1.57219 | 1.57219 | 1.57219 | 1.57219 | 1.57219 |
| Other Long Term Assets, Total | 0.00769 | 0.00769 | 0.00769 | 0.00769 | 0.00769 |
| Total Current Liabilities | 0.82783 | 1.31113 | 1.08936 | 0.70437 | 0.61298 |
| Accounts Payable | 0.44594 | 0.86128 | 0.55903 | 0.20536 | 0.09286 |
| Accrued Expenses | 0.3819 | 0.44986 | 0.53033 | 0.49901 | 0.52012 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Total Liabilities | 0.82783 | 1.31113 | 1.08936 | 0.70437 | 0.61298 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | |||||
| Total Equity | 77.1227 | 81.0376 | 86.2957 | 89.9198 | 91.3302 |
| Common Stock | 0.00216 | 0.00216 | 0.00216 | 0.00207 | 0.00207 |
| Additional Paid-In Capital | 202.231 | 201.601 | 201.593 | 201.582 | 201.573 |
| Retained Earnings (Accumulated Deficit) | -115.838 | -115.074 | -113.194 | -111.649 | -110.226 |
| Other Equity, Total | -0.01773 | -0.01517 | -0.01445 | -0.01576 | -0.0193 |
| Total Liabilities & Shareholders’ Equity | 77.9505 | 82.3487 | 87.3851 | 90.6241 | 91.9432 |
| Total Common Shares Outstanding | 18.209 | 20.7211 | 20.7501 | 20.7211 | 20.7202 |
| Treasury Stock - Common | -9.25401 | -5.47589 | -2.09085 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -4.23916 | -3.55124 | -3.82689 | -4.06723 | -6.82884 |
| Efectivo de actividades de explotación | -4.11732 | -3.33089 | -2.33837 | -2.87791 | -5.0794 |
| Partidas no monetarias | 0.1128 | 0.36596 | 1.22117 | 1.02222 | 1.83532 |
| Intereses pagados en efectivo | 0.00051 | 0.00227 | 0.00045 | ||
| Cambios en el capital circulante | 0.00904 | -0.14561 | 0.26735 | 0.1671 | -0.08587 |
| Efectivo de actividades de inversión | 0 | 0 | 0 | 0 | 0 |
| Otras partidas de flujo de caja de inversión, total | 0 | 0 | 0 | 0 | 0 |
| Efectivo procedente de actividades de financiación | 87.3112 | 4.63681 | 2.72585 | 2.3425 | 2.68141 |
| Emisión (retiro) de acciones, neto | 87.3621 | 4.69925 | 2.663 | 2.3425 | 2.68141 |
| Emisión (amortización) de deuda, neta | -0.05081 | -0.06244 | 0.06285 | ||
| Efectos del cambio de divisas | 0.00463 | 0.00133 | -0.00787 | -0.00913 | -0.00645 |
| Variación neta de la tesorería | 83.1985 | 1.30725 | 0.37961 | -0.54455 | -2.40443 |
| Cash Taxes Paid | 0.0016 | 0.0008 | 0.0008 |
| Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -4.18966 | -3.42552 | -1.54501 | -4.23916 | -2.81645 |
| Cash From Operating Activities | -3.50534 | -2.96364 | -1.08438 | -4.11732 | -2.92548 |
| Non-Cash Items | 0.81355 | 0.01775 | 0.00962 | 0.1128 | 0.10406 |
| Cash Taxes Paid | 0 | 0 | 0 | 0.0016 | 0.0016 |
| Cash Interest Paid | 0 | 0 | 0 | 0.00051 | 0.00051 |
| Changes in Working Capital | -0.12924 | 0.44413 | 0.45101 | 0.00904 | -0.21309 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | |
| Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
| Cash From Financing Activities | -9.25313 | -5.47501 | -2.08997 | 87.3112 | 87.3621 |
| Issuance (Retirement) of Stock, Net | -9.25313 | -5.47501 | -2.08997 | 87.3621 | 87.3621 |
| Issuance (Retirement) of Debt, Net | -0.05081 | 0 | |||
| Foreign Exchange Effects | -0.00197 | 0.00058 | 0.0013 | 0.00463 | 0.00108 |
| Net Change in Cash | -12.7604 | -8.43807 | -3.17304 | 83.1985 | 84.4377 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | Hedge Fund | 6.7317 | 1174245 | -147254 | 2023-05-11 | |
| Intracoastal Capital, L.L.C. | Corporation | 6.3408 | 1106042 | 374560 | 2022-12-31 | |
| Ayrton Capital LLC | Hedge Fund | 5.9079 | 1030530 | -2600 | 2023-03-31 | MED |
| K2 & Associates Investment Management Inc. | Hedge Fund | 4.1464 | 723271 | -8834 | 2023-03-31 | HIGH |
| Farb (Daniel Stuart) | Individual Investor | 4.0965 | 714570 | 714570 | 2022-11-01 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.0213 | 701450 | 46933 | 2023-03-31 | LOW |
| Equitec Proprietary Markets, LLC | Investment Advisor | 1.8958 | 330694 | 0 | 2023-03-31 | HIGH |
| Asher (Daniel B) | Individual Investor | 1.8958 | 330694 | 330694 | 2022-12-31 | |
| Allen (Daniel C) | Individual Investor | 1.4905 | 260000 | 260000 | 2022-11-01 | |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0048 | 175264 | 0 | 2023-03-31 | LOW |
| Simplex Trading, LLC | Research Firm | 0.7636 | 133200 | 69592 | 2023-03-31 | HIGH |
| Susquehanna International Group, LLP | Investment Advisor | 0.6128 | 106886 | 106886 | 2023-03-31 | MED |
| Citadel Advisors LLC | Hedge Fund | 0.4358 | 76011 | 58508 | 2023-03-31 | HIGH |
| Abbe (Richard) | Individual Investor | 0.392 | 68370 | 0 | 2023-05-11 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3589 | 62600 | 0 | 2023-03-31 | LOW |
| Schechter (Jonathan L) | Individual Investor | 0.2866 | 50000 | 0 | 2022-11-01 | MED |
| Silverman (Joshua N.) | Individual Investor | 0.2866 | 50000 | 0 | 2022-11-01 | |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2369 | 41331 | 29991 | 2023-03-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.168 | 29303 | 5379 | 2023-03-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1677 | 29248 | -8371 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
PharmaCyte Biotech, Inc. Company profile
Sobre Pharmacyte Biotech Inc
PharmaCyte Biotech, Inc. es una empresa de biotecnología en fase clínica. La empresa se centra en el desarrollo de terapias celulares contra el cáncer y la diabetes basadas en una tecnología de encapsulación de células vivas a base de celulosa conocida como Cell-in-a-Box. La tecnología Cell-in-a-Box se utiliza como plataforma sobre la que se desarrollan terapias para varios tipos de cáncer, incluido el cáncer de páncreas localmente avanzado, inoperable y no metastásico (LAPC). El principal producto candidato de la empresa, CypCaps, se encuentra en la fase II de los ensayos clínicos en LAPC. También se centra en el desarrollo de una terapia para la diabetes de tipo 1 y la diabetes de tipo 2 dependiente de la insulina. Su producto candidato para el tratamiento de la diabetes consiste en la encapsulación de células productoras de insulina genéticamente modificadas. La empresa también se centra en los beneficios de la tecnología Cell-in-a-Box para desarrollar terapias contra el cáncer que implican profármacos basados en ciertos componentes de la planta de Cannabis, como los cannabinoides.
El precio actual de la acción PharmaCyte Biotech, Inc. en tiempo real es 3.11 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: $ Acromec, REX American Resources Corporat, Ipsos SA, Taiwan Semiconductor Manufacturing, Hugo Boss AG y AST SpaceMobile, Inc.. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Pharmaceuticals (NEC) |
23046 Avenida De La Carlota, Suite 600
LAGUNA HILLS
CALIFORNIA 92653
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com